Log in

NYSE:MPW - Medical Properties Trust Stock Price, Forecast & News

$24.08
+0.47 (+1.99 %)
(As of 02/17/2020 03:06 AM ET)
Add
Today's Range
$23.62
Now: $24.08
$24.09
50-Day Range
$20.71
MA: $22.05
$24.08
52-Week Range
$16.83
Now: $24.08
$24.09
Volume2.71 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio28.00
Dividend YieldN/A
BetaN/A
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustrySpecialized REITs
SectorN/A
CUSIP58463J30
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees77
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable

Receive MPW News and Ratings via Email

Sign-up to receive the latest news and ratings for MPW and its competitors with MarketBeat's FREE daily newsletter.


Medical Properties Trust (NYSE:MPW) Frequently Asked Questions

What is Medical Properties Trust's stock symbol?

Medical Properties Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MPW."

How often does Medical Properties Trust pay dividends? What is the dividend yield for Medical Properties Trust?

Medical Properties Trust declared a quarterly dividend on Thursday, November 21st. Investors of record on Thursday, December 12th will be given a dividend of $0.26 per share on Thursday, January 9th. This represents a $1.04 annualized dividend and a yield of 4.32%. The ex-dividend date of this dividend is Wednesday, December 11th. View Medical Properties Trust's Dividend History.

How were Medical Properties Trust's earnings last quarter?

Medical Properties Trust, Inc. (NYSE:MPW) posted its earnings results on Thursday, February, 6th. The real estate investment trust reported $0.26 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.35 by $0.09. The real estate investment trust had revenue of $256.44 million for the quarter, compared to analyst estimates of $263.35 million. The company's revenue for the quarter was up 42.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.31 earnings per share. View Medical Properties Trust's Earnings History.

When is Medical Properties Trust's next earnings date?

Medical Properties Trust is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for Medical Properties Trust.

What guidance has Medical Properties Trust issued on next quarter's earnings?

Medical Properties Trust issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of 1.65-1.68 for the period.

What price target have analysts set for MPW?

10 brokers have issued 12-month target prices for Medical Properties Trust's stock. Their forecasts range from $16.00 to $26.00. On average, they expect Medical Properties Trust's share price to reach $21.35 in the next year. This suggests that the stock has a possible downside of 11.3%. View Analyst Price Targets for Medical Properties Trust.

What is the consensus analysts' recommendation for Medical Properties Trust?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Properties Trust.

Has Medical Properties Trust been receiving favorable news coverage?

News coverage about MPW stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medical Properties Trust earned a news impact score of 1.8 on InfoTrie's scale. They also gave news stories about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Medical Properties Trust.

Who are some of Medical Properties Trust's key competitors?

What other stocks do shareholders of Medical Properties Trust own?

Who are Medical Properties Trust's key executives?

Medical Properties Trust's management team includes the folowing people:
  • Mr. Edward K. Aldag Jr., Chairman, Pres & CEO (Age 55)
  • Mr. Emmett E. McLean, Co-Founder, COO, Exec. VP, Treasurer & Sec. (Age 64)
  • Mr. R. Steven Hamner, Exec. VP, CFO & Director (Age 62)
  • Mr. James Kevin Hanna, Chief Accounting Officer, VP & Controller (Age 46)
  • Mr. Tim Berryman, Director, Investor Relations

Who are Medical Properties Trust's major shareholders?

Medical Properties Trust's stock is owned by a number of of retail and institutional investors. Top institutional investors include Cohen & Steers Inc. (6.13%), State Street Corp (4.44%), Bank of New York Mellon Corp (2.82%), Massachusetts Financial Services Co. MA (2.24%), Daiwa Securities Group Inc. (1.50%) and Principal Financial Group Inc. (1.34%). Company insiders that own Medical Properties Trust stock include Edward K Aldag Jr, Emmett E Mclean, G Steven Dawson, Holzgrefe Richard, James Kevin Hanna, Michael G Stewart and R Steven Hamner. View Institutional Ownership Trends for Medical Properties Trust.

Which institutional investors are selling Medical Properties Trust stock?

MPW stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, Massachusetts Financial Services Co. MA, Panagora Asset Management Inc., Assetmark Inc., Guardian Capital LP, Cipher Capital LP, Sei Investments Co. and Guggenheim Capital LLC. Company insiders that have sold Medical Properties Trust company stock in the last year include Edward K Aldag Jr, Emmett E Mclean, Michael G Stewart and R Steven Hamner. View Insider Buying and Selling for Medical Properties Trust.

Which institutional investors are buying Medical Properties Trust stock?

MPW stock was acquired by a variety of institutional investors in the last quarter, including Cohen & Steers Inc., State Street Corp, Sumitomo Mitsui Trust Holdings Inc., UBS Asset Management Americas Inc., Russell Investments Group Ltd., Swiss National Bank, UBS Group AG and Barclays PLC. Company insiders that have bought Medical Properties Trust stock in the last two years include G Steven Dawson and Holzgrefe Richard. View Insider Buying and Selling for Medical Properties Trust.

How do I buy shares of Medical Properties Trust?

Shares of MPW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medical Properties Trust's stock price today?

One share of MPW stock can currently be purchased for approximately $24.08.


MarketBeat Community Rating for Medical Properties Trust (NYSE MPW)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  353 (Vote Outperform)
Underperform Votes:  443 (Vote Underperform)
Total Votes:  796
MarketBeat's community ratings are surveys of what our community members think about Medical Properties Trust and other stocks. Vote "Outperform" if you believe MPW will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MPW will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: Overbought

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel